https://european-biotechnology.net/wp-content/uploads/2025/02/Friedrich-Merz-1030x484-1.jpg
484
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-24 10:15:282025-02-24 10:15:28New German Chancellor wants a strong Europe
https://european-biotechnology.net/wp-content/uploads/2025/02/EG-427-nHSV-vectors-1030x404-1.png
404
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-20 06:10:162025-02-20 11:32:01French EG 427 bags €27m in Series B financing
https://european-biotechnology.net/wp-content/uploads/2025/02/Catumaxomab_mechanism.svg_-1030x467-1.png
467
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-19 14:25:582025-02-19 14:25:58Lindis Biotech selects Celonic Group for commercial manufacturing of catumaxomab
https://european-biotechnology.net/wp-content/uploads/2025/02/Cultivated-B-e1739972207647.jpg
541
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-19 11:31:332025-02-19 15:02:02Cultivated B solves fetal bovine serum problem
https://european-biotechnology.net/wp-content/uploads/2025/02/Photo-Marvin-Amberg-Credit-Yves-Callewaert-1030x697-1.png
697
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-18 14:06:122025-02-18 14:06:12naturalX secures €100m to fuel the future of consumer health in Europe
https://european-biotechnology.net/wp-content/uploads/2025/02/BRAIN_Nugget_Biogold_Copyright_PX_Group-e1739437420868-1030x580-1.png
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-13 09:22:492025-02-13 09:22:49BRAIN Biotech partners with PX Group in microbial gold recycling
https://european-biotechnology.net/wp-content/uploads/2025/02/Mourenx.jpg
432
768
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-12 10:22:452025-02-13 14:32:02Axplora Group announces €50m expansion of GLP-1 manufacturing site
https://european-biotechnology.net/wp-content/uploads/2025/02/Ethris_1000_F_1006771540_WmJ77Me3nsAanRvFGsKP45Cnl6IhcOhJ.jpg
560
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-12 06:04:042025-02-12 06:04:04Ethris GmbH bags US$5m from CEPI
https://european-biotechnology.net/wp-content/uploads/2025/02/Bioeconomy-Alliance-e1739187465395.jpg
358
640
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-10 11:40:432025-02-10 11:40:43The European Alliance for the Bioeconomy wants to bring back economic growth
https://european-biotechnology.net/wp-content/uploads/2025/02/sCD83_mode_of_action-e1738740802803.png
364
602
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-05 07:33:492025-02-05 07:33:49Mallia selects Northway to produce alopecia therapy
Scroll to top
